COVID-19NCT05212974
COVID-19 Vaccine Hesitancy Among Nurses
An observational study of COVID-19 and Vaccine Hesitancy, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. Read more about this study
- Who is it for?
- Ages 20 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- COVID-19, Vaccine Hesitancy, Vaccination
- What is being tested?
- Questionnaires
- Type of treatment
- Vaccines
- How many people
- 4,258 participants
- Where
- 1 siteTaiwan
- Study dates
- 22 Feb 2022to 19 May 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: [Nurses] Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license. [General publics] Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.
Who may be able to join
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have verification of registered nurse license.
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have reading abilities above the intermediate level.
Who cannot join
- Male and female participants be>80 years at the time of informed consent.
- [General publics]
- Male and female participants be>80 years at the time of informed consent.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.
Read the detailed description
A cross-sectional study based on convenience samples. The investigators recruit nurses and the general public to respond to structured self-filling electronic questionnaires by using an electronic data collection system. The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items. Convenience sampling was applied to estimate the sample size according to the number of nurses in each county. It is planned to collect a total of 4258 responses by the end of the study. The study instrument is the 5C psychological antecedents of vaccination, which includes Confidence, Complacency, Constraints, Calculation, and Collective Responsibility.
- Conditions
- COVID-19, Vaccine Hesitancy, Vaccination, Nurses
- Being tested
- Questionnaires
- Medical subject headings
- COVID-19, Vaccination Hesitancy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnairesOther
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.
| Study group | Role | What they receive |
|---|---|---|
| Nurses | Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license. Receives: Other: Questionnaires | |
| General publics | Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level. Receives: Other: Questionnaires |
What is being measured
The primary outcome is the main question the study is designed to answer.
The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics.
The 5C scale measures the psychological antecedents of vaccination, using 15 item tools including 5 domains (confidence, complacency, constraints, calculation, and collective responsibility). Each domain was assessed by 3 rating items on a 7-point scale (1=strongly disagree; 7=strongly agree). The mean scores of items under each domain were computed, with a higher average score indicating stronger agreement of the corresponding domain.
Measured: The questionnaire length around 10 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jan 2022
- Study start22 Feb 2022
- Primary completion19 May 2022
- Study completion19 May 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COVID-19Studies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 4,258 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jung-Chen Chang, Ph.D, Principal investigator, Department of Nursing, National Taiwan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05212974
- Sponsor's protocol ID
- 202106114RINA
- Status last verified
- May 2023
- First submitted
- 24 Jan 2022
- Last updated
- 9 Jul 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COVID-19 Vaccine Hesitancy Among Nurses
- ClinicalTrials.gov ID
- NCT05212974
- Acronym / sponsor ID
- 202106114RINA
- Conditions
- COVID-19, Vaccine Hesitancy, Vaccination, Nurses
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,258 participants (actual)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 22 Feb 2022 (actual)
- Primary completion
- 19 May 2022 (actual)
- Study completion
- 19 May 2022 (actual)
- First posted
- 28 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.
Detailed description
A cross-sectional study based on convenience samples. The investigators recruit nurses and the general public to respond to structured self-filling electronic questionnaires by using an electronic data collection system. The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items. Convenience sampling was applied to estimate the sample size according to the number of nurses in each county. It is planned to collect a total of 4258 responses by the end of the study. The study instrument is the 5C psychological antecedents of vaccination, which includes Confidence, Complacency, Constraints, Calculation, and Collective Responsibility.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Nurses | – | Other: QuestionnairesAdult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license. |
| General publics | – | Other: QuestionnairesAdult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level. |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- [Nurses] Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license. [General publics] Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.
Key inclusion criteria (4 listed)
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have verification of registered nurse license.
- Male and female participants must be ≥ 20 years at the time of informed consent.
- Male and female participants have reading abilities above the intermediate level.
Key exclusion criteria (3 listed)
- Male and female participants be>80 years at the time of informed consent.
- [General publics]
- Male and female participants be>80 years at the time of informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnairesThe questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items. | Other | General publics, Nurses |
Primary outcome
The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics.
Time frame: The questionnaire length around 10 minutes.
The 5C scale measures the psychological antecedents of vaccination, using 15 item tools including 5 domains (confidence, complacency, constraints, calculation, and collective responsibility). Each domain was assessed by 3 rating items on a 7-point scale (1=strongly disagree; 7=strongly agree). The mean scores of items under each domain were computed, with a higher average score indicating stronger agreement of the corresponding domain.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2024.
Related trials for COVID-19
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruiting
Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement
COVID-19
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
RecruitingPhase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Respiratory Tract Diseases, Influenza (Pandemic)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jung-Chen Chang, Ph.D principal investigator
Department of Nursing, National Taiwan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 and Vaccine Hesitancy, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics. (time frame: The questionnaire length around 10 minutes.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2024.